This company seems to have been delisted
Reason: Liquidation
Last recorded trade on: February 20, 2025
Source: https://globalgenes.org/raredaily/bellerophons-board-agrees-to-liquidate-after-trial-failures-and-layoffs/
Reason: Liquidation
Last recorded trade on: February 20, 2025
Source: https://globalgenes.org/raredaily/bellerophons-board-agrees-to-liquidate-after-trial-failures-and-layoffs/
Bellerophon Therapeutics
BLPH
S$0.01527
Share price
-36.84%
Change (1 day)
-81.19%
Change (1 year)
Categories
Bellerophon Therapeutics (BLPH) - Total assets
Total assets on the balance sheet as of September 2023 : S$6.33 Million
According to Bellerophon Therapeutics 's latest financial reports the company's total assets are S$6.33 Million. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Bellerophon Therapeutics - Total assets on balance sheet (from 2013 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | S$10.63 M | -70.72% |
| 2021-12-31 | S$36.33 M | -45.33% |
| 2020-12-31 | S$66.46 M | 276.09% |
| 2019-12-31 | S$17.67 M | -29.54% |
| 2018-12-31 | S$25.08 M | -49.05% |
| 2017-12-31 | S$49.23 M | 14.53% |
| 2016-12-31 | S$42.98 M | -20.88% |
| 2015-12-31 | S$54.33 M | 23.14% |
| 2014-12-31 | S$44.12 M | 857.75% |
| 2013-12-31 | S$4.6 M | 12.48% |
| 2012-12-31 | S$4.09 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Baxter BAX | S$27.11 B | 427,777.08% | 🇺🇸 USA |
 Abeona Therapeutics
ABEO | S$0.12 B | 1,895.66% | 🇺🇸 USA |
 Abbott Laboratories ABT | S$103.66 B | 1,635,730.49% | 🇺🇸 USA |
 Lantheus Holdings LNTH | S$2.61 B | 41,177.77% | 🇺🇸 USA |